Disrupt The Disorder – Trademark Portfolio

Entity Type: 16

Disrupt The Disorder holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DISRUPT THE DISORDER. The owner is based in WASHINGTON, DC.

#105

805 Channing Pl NE

WASHINGTON, DC 20018

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Disrupt The Disorder's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Disrupt The Disorder have?

Disrupt The Disorder has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Disrupt The Disorder file in?

Disrupt The Disorder files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Disrupt The Disorder's most well-known trademarks?

Disrupt The Disorder's registered trademark portfolio includes well-known marks such as DISRUPT THE DISORDER. These are among 1 currently registered trademark in the portfolio.

What is Disrupt The Disorder's trademark registration success rate?

Disrupt The Disorder has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.